Form 8-K - Current report:
SEC Accession No. 0001493152-22-021011
Filing Date
2022-08-02
Accepted
2022-08-02 16:30:30
Documents
12
Period of Report
2022-07-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34096
  Complete submission text file 0001493152-22-021011.txt   207312

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20220729.xsd EX-101.SCH 2956
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20220729_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20220729_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3744
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 221129139
SIC: 2834 Pharmaceutical Preparations